v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS – OPERATING ACTIVITIES    
Net loss $ (17,727) $ (26,169)
Adjustments required to reconcile net loss to cash flows used in operating activities    
Depreciation 1,803 871
Stock-based compensation 1,848 1,059
Amortization of debt issuance costs 567
Finance income, net (435) (128)
Revaluation of contingent consideration (78) (33)
Income from change in fair value of Private Placement Warrants (26,458)
Private Placement Warrants issuance cost 732
Changes in contract liability (1,976)
Loss from sale and disposal of fixed assets, net 221 71
Goodwill impairment 801
IPR&D impairment 3,237
Long-lived assets impairment 4,046
Changes in operating assets and liabilities:    
Other current assets 842 819
Trade account payables (3,167) 556
Other account payables (984) 1,194
Net change in operating leases 316 (93)
Net cash used in operating activities (36,979) (21,286)
CASH FLOWS – INVESTING ACTIVITIES    
Cash and restricted cash acquired from the APT acquisition 663
Proceeds from short-term deposits 2,000
Purchase of property and equipment (30) (50)
Proceeds from sale of property and equipment 82 1
Net cash provided by investing activities 715 1,951
CASH FLOWS – FINANCING ACTIVITIES    
Issuance of Common Stock and warrants under February 2023 PIPE 7,485
Issuance costs from February 2023 PIPE (333)
Pre-Funded Warrants exercise 6
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs 19
Repayment of long-term debt (10,747) (4,253)
Issuance of Private Placement Warrants under March 2024 PIPE 28,745
Issuance of Redeemable Convertible Preferred Shares under March 2024 PIPE 21,269
March 2024 PIPE issuance costs (918)
Net cash provided by financing activities 38,374 2,899
Increase (decrease) in cash and cash equivalents and restricted cash 2,110 (16,436)
Effect of exchange rate changes on cash and cash equivalents and restricted cash 1 6
Cash and cash equivalents and restricted cash at the beginning of the year 15,864 32,294
Cash and cash equivalents and restricted cash at the end of the year 17,975 15,864
Cash and cash equivalents 16,856 14,907
Restricted cash 1,119 957
Total cash and cash equivalents and restricted cash 17,975 15,864
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid for interest 1,442 1,873
Taxes paid 13 54
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:    
Property and equipment purchases included in accounts payable 1 5
Issuance cost from March 2024 PIPE 1,273
Issuance of Common Stock under the APT acquisition 3,041
Issuance of Redeemable Convertible Preferred Shares under the APT acquisition 12,610
Issuance of Merger Warrants under the APT acquisition 200
Redeemable Convertible Preferred Shares conversion into shares of Common Stock $ 13,774

Source